Literature DB >> 20512952

Recent advances in the management of primary hepatic tumors refinement of surgical techniques and effect on outcome.

Rohit Sharma1, John F Gibbs.   

Abstract

Advances in diagnostic, anesthetic, and surgical techniques have led to significant reductions in perioperative morbidity and mortality. The preoperative factors that have been of particular importance are a careful evaluation of hepatic function and of the predicted future liver remnant (FLR) volume prior to a decision on the feasibility of resection. Better patient selection, increased understanding of the liver anatomy leading to anatomical resections has together led to marked improvement in outcomes. In this article, we discuss the pre- and intraoperative factors, which have evolved in the last decade influencing the trend towards increased safety. We also share our technique of liver resection. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20512952     DOI: 10.1002/jso.21506

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.

Authors:  Clancy J Clark; Christina M Wood-Wentz; Kaye M Reid-Lombardo; Michael L Kendrick; Marianne Huebner; Florencia G Que
Journal:  HPB (Oxford)       Date:  2011-09       Impact factor: 3.647

Review 2.  Surrogate endpoints in liver surgery related trials: a systematic review of the literature.

Authors:  Liliane Mpabanzi; Kim M C van Mierlo; Massimo Malagó; Cornelis H C Dejong; Dimitrios Lytras; Steven W M Olde Damink
Journal:  HPB (Oxford)       Date:  2012-10-22       Impact factor: 3.647

3.  Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.

Authors:  Jun-Jie Xiong; Kiran Altaf; Muhammad A Javed; Wei Huang; Rajarshi Mukherjee; Gang Mai; Robert Sutton; Xu-Bao Liu; Wei-Ming Hu
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

4.  Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma.

Authors:  Qunfang Zhou; Fei Tuo; Ruixia Li; Xiaohui Wang; Juncheng Wang; Zhimei Huang; Minshan Chen; Jinhua Huang
Journal:  Front Oncol       Date:  2020-11-04       Impact factor: 6.244

5.  Predictors of intraoperative blood loss in patients undergoing hepatectomy.

Authors:  Atsushi Nanashima; Takafumi Abo; Keiko Hamasaki; Kouki Wakata; Masaki Kunizaki; Kazuo Tou; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Tomoshi Tsuchiya; Takeshi Nagayasu
Journal:  Surg Today       Date:  2012-10-20       Impact factor: 2.549

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.